Latest Insider Transactions at Nutex Health, Inc. (NUTX)
This section provides a real-time view of insider transactions for Nutex Health, Inc. (NUTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nutex Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nutex Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2022
|
Lawrence Schimmel Chief Medical Information Off |
BUY
Conversion of derivative security
|
Direct |
19,597
+7.17%
|
$19,597
$1.55 P/Share
|
|
Apr 01
2022
|
Thomas T. Vo Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
267,728,389
+50.0%
|
-
|
|
Apr 01
2022
|
Michael L. Chang Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
12,008,523
+50.0%
|
-
|
|
Apr 01
2022
|
Matthew Stephen Young Director |
BUY
Grant, award, or other acquisition
|
Indirect |
42,134,210
+50.0%
|
-
|
|
Feb 25
2021
|
Warren Hosseinion President |
BUY
Other acquisition or disposition
|
Direct |
894,209
+43.71%
|
$1,788,418
$2.04 P/Share
|
|
Jan 28
2021
|
Mark Fawcett Director |
BUY
Other acquisition or disposition
|
Direct |
268,263
+49.18%
|
$536,526
$2.04 P/Share
|
|
Jan 28
2021
|
Elisa V Luqman Chief Legal Officer-SEC |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+10.44%
|
$1,500
$1.61 P/Share
|
|
Jan 28
2021
|
Lawrence Schimmel Chief Medical Information Off |
BUY
Grant, award, or other acquisition
|
Direct |
107,692
+31.51%
|
$0
$0.65 P/Share
|